Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China
Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China have?
Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China has 19 citations in the OpenAlex counts ScholarIQ stores.
When was Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China published?
Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China has 2021 year in the ScholarIQ index.
What is the open-access status of Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China?
Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China has gold oa status in the ScholarIQ index.
What is the DOI of Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China?
The DOI for Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China is on the source record.
What is the PMID of Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China?
The PMID for Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China is on the source record.
What is the OpenAlex record for Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China?
The OpenAlex for Synchronous bone metastasis in lung cancer: retrospective study of a single center of 15,716 patients from Tianjin, China is on the source record.